Patents Assigned to RejuvGen Pharmaceuticals, Inc.
  • Polyhydroxyphthalazinone compound, preparation method thereof and use thereof
    Patent number: 10640469
    Abstract: The present disclosure provides a polyhydroxyphthalazinone compound, preparation method thereof and use thereof, wherein the general formula of chemical structure of the polyhydroxyphthalazinone compound is shown by the formula (I). The polyhydroxyphthalazinone compound disclosed by the present disclosure has a good effect on activating ER? receptor, and it is expected to develop a novel ER-? receptor agonist.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: May 5, 2020
    Assignee: RejuvGen Pharmaceuticals, Inc.
    Inventors: Faxiang Liang, Yanling Ding